IRS
PFE icon

Invictus RG (Singapore)’s Pfizer PFE Stock Holding History

Invictus RG (Singapore)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-839
Closed -$25K – 321
2015
Q3 		$25K Sell
839
-2,713
-76% -$87K 0.02% 453
2015
Q2 		$113K Sell
3,552
-8,885
-71% -$290K 0.11% 301
2015
Q1 		$411K Buy
12,437
+5,053
+68% +$161K 0.39% 73
2014
Q4 		$218K Sell
7,384
-3,157
-30% -$90.5K 0.24% 178
2014
Q3 		$296K Buy
10,541
+2,107
+25% +$59.1K 0.37% 66
2014
Q2 		$237K Buy
8,434
+6,514
+339% +$186K 0.25% 147
2014
Q1 		$59K Sell
1,920
-14,500
-88% -$432K 0.07% 335
2013
Q4 		$477K Sell
16,420
-4,424
-21% -$129K 0.32% 91
2013
Q3 		$568K Buy
20,844
+13,825
+197% +$376K 0.48% 33
2013
Q2 		$187K Buy
+7,019
New +$194K 0.21% 173

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invictus RG (Singapore)'s PFE Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Pfizer (PFE) in Q4 2015, closing a stake of 839 shares — an estimated $25K sold.

Invictus RG (Singapore) first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $568K in Q3 2013. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 839 Pfizer shares in Q4 2015, an estimated $25K.
  • Invictus RG (Singapore) first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
  • Invictus RG (Singapore)'s Pfizer position peaked at $568K in Q3 2013.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.